Pharma Group Consolidates Three DAMs into One on Jahia

Following three acquisitions, HelixPharma operated three separate DAM systems with incompatible metadata schemas, duplicated assets across all three, and no way for regional marketing teams to find regulatory-approved images without emailing the central brand team.

All three DAMs were migrated into a single Jahia DAM instance with a unified metadata schema covering product lines, regulatory approval status, expiry dates, and market availability. AI-assisted deduplication removed 40% of redundant assets during migration. Role-based access restricts regulated assets to approved markets only.

Asset search time dropped from 25 minutes to under 2 minutes. Regulatory non-compliance incidents from expired asset usage eliminated entirely. Annual DAM licensing and storage costs reduced by 58%. The brand team's asset request queue — previously 300+ tickets per month — fell to zero.